company background image
34D logo

DiaSorin DB:34D Stock Report

Last Price

€87.12

Market Cap

€4.7b

7D

-6.3%

1Y

-11.0%

Updated

26 Mar, 2024

Data

Company Financials +

34D Stock Overview

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China.

34D fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance2/6
Financial Health3/6
Dividends4/6

DiaSorin S.p.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for DiaSorin
Historical stock prices
Current Share Price€87.12
52 Week High€105.25
52 Week Low€80.98
Beta0.15
1 Month Change-6.20%
3 Month Change-6.22%
1 Year Change-10.96%
3 Year Change-36.36%
5 Year Change-3.09%
Change since IPO603.72%

Recent News & Updates

Recent updates

Shareholder Returns

34DDE Medical EquipmentDE Market
7D-6.3%-1.2%1.9%
1Y-11.0%4.3%7.3%

Return vs Industry: 34D underperformed the German Medical Equipment industry which returned 2.8% over the past year.

Return vs Market: 34D underperformed the German Market which returned 6.4% over the past year.

Price Volatility

Is 34D's price volatile compared to industry and market?
34D volatility
34D Average Weekly Movement3.2%
Medical Equipment Industry Average Movement5.0%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.1%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 34D has not had significant price volatility in the past 3 months.

Volatility Over Time: 34D's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19683,278Carlo Rosahttps://diasoringroup.com/en

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System.

DiaSorin S.p.A. Fundamentals Summary

How do DiaSorin's earnings and revenue compare to its market cap?
34D fundamental statistics
Market cap€4.67b
Earnings (TTM)€159.00m
Revenue (TTM)€1.15b

29.4x

P/E Ratio

4.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
34D income statement (TTM)
Revenue€1.15b
Cost of Revenue€407.00m
Gross Profit€741.00m
Other Expenses€582.00m
Earnings€159.00m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 10, 2024

Earnings per share (EPS)2.98
Gross Margin64.55%
Net Profit Margin13.85%
Debt/Equity Ratio68.7%

How did 34D perform over the long term?

See historical performance and comparison

Dividends

1.3%

Current Dividend Yield

34%

Payout Ratio

Does 34D pay a reliable dividends?

See 34D dividend history and benchmarks
When do you need to buy 34D by to receive an upcoming dividend?
DiaSorin dividend dates
Ex Dividend DateMay 20 2024
Dividend Pay DateMay 22 2024
Days until Ex dividend53 days
Days until Dividend pay date55 days

Does 34D pay a reliable dividends?

See 34D dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.